Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer
- 15 February 2011
- Vol. 117 (16), 3774-3780
- https://doi.org/10.1002/cncr.25933
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapyThe Journal of Nutritional Biochemistry, 2008
- Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trialsLung Cancer, 2006
- n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexiaNutrition Research Reviews, 2004
- Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2European Journal of Nutrition, 2003
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2002
- Lung Cancer — Time to Move on from ChemotherapyThe New England Journal of Medicine, 2002
- Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group TrialJournal of Clinical Oncology, 2001
- Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatinCancer Chemotherapy and Pharmacology, 2000
- Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effectsBritish Journal of Cancer, 1999
- Dietary n‐3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicityLipids, 1999